» Articles » PMID: 12732260

Inhibition of Protein Phosphatase 2A- and Protein Phosphatase 1-induced Tau Hyperphosphorylation and Impairment of Spatial Memory Retention in Rats

Overview
Journal Neuroscience
Specialty Neurology
Date 2003 May 7
PMID 12732260
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Tau hyperphosphorylation leads to formation of paired helical filament/neurofibrillary tangles, the hallmark lesion seen in Alzheimer's disease (AD) brain. An imbalanced regulation in protein kinases and protein phosphatases in the affected neurons is proposed to be a reasonable causative factor to the disease process. To verify the hypothesis, we have injected in the present study calyculin A, a potent and specific inhibitor of protein phosphatase (PP) 2A and PP1, into rat hippocampus bilaterally, thus reproduced an Alzheimer's-like deficiency in dephosphorylation system. It was found that calyculin A-injected rats developed lesions in spatial memory retention in Morris water maze test. At mean time, tau was hyperphosphorylated at Ser396/Ser404 (PHF-1) and Ser-262/Ser-356 (12E8) sites determined both by immunohistochemistry and Western blot. It is implicated that (1) PP2A and PP1 participate in the in vivo regulation of tau phosphorylation, and down-regulation of the two phosphatases will result in tau hyperphosphorylation; (2) hyperphosphorylation of tau at PHF-1 and 12E8 sites might be crucial to affect spatial memory in AD.

Citing Articles

PP1γ regulates neuronal insulin signaling and aggravates insulin resistance leading to AD-like phenotypes.

Yadav Y, Sharma M, Dey C Cell Commun Signal. 2023; 21(1):82.

PMID: 37085815 PMC: 10120118. DOI: 10.1186/s12964-023-01071-x.


RNAseq Analysis of FABP4 Knockout Mouse Hippocampal Transcriptome Suggests a Role for WNT/β-Catenin in Preventing Obesity-Induced Cognitive Impairment.

So S, Nixon J, Bernlohr D, Butterick T Int J Mol Sci. 2023; 24(4).

PMID: 36834799 PMC: 9961923. DOI: 10.3390/ijms24043381.


Evaluation of Quantification and Normalization Strategies for Phosphoprotein Phosphatase Affinity Proteomics: Application to Breast Cancer Signaling.

Brauer B, Wiredu K, Gerber S, Kettenbach A J Proteome Res. 2022; 22(1):47-61.

PMID: 36448918 PMC: 10625046. DOI: 10.1021/acs.jproteome.2c00465.


Nanomedicines in the Management of Alzheimer's Disease: Current View and Future Prospects.

Chopra H, Bibi S, Singh I, Kamal M, Islam F, Alhumaydhi F Front Aging Neurosci. 2022; 14:879114.

PMID: 35875806 PMC: 9304964. DOI: 10.3389/fnagi.2022.879114.


Zinc in Regulating Protein Kinases and Phosphatases in Neurodegenerative Diseases.

Zhang H, Wang X, Liu R Biomolecules. 2022; 12(6).

PMID: 35740910 PMC: 9220840. DOI: 10.3390/biom12060785.